Carl Goldfischer's Net Worth
$1.52 Million
Who is Carl Goldfischer?
Carl Goldfischer has an estimated net worth of $1.52 Million. This is based on reported shares across multiple companies, which include EnteroMedics Inc, MAP Pharmaceuticals, Inc., ZVUE CORP, CymaBay Therapeutics, Inc., PONIARD PHARMACEUTICALS, INC., Galecto, Inc., Epizyme, Inc., and IMARA Inc..
SEC CIK
Carl Goldfischer's CIK is 0001110780
Past Insider Trading and Trends
2007 was Carl Goldfischer's most active year for acquiring shares with 24 total transactions. Carl Goldfischer's most active month to acquire stocks was the month of May. 2014 was Carl Goldfischer's most active year for disposing of shares, totalling 13 transactions. Carl Goldfischer's most active month to dispose stocks was the month of February. 2007 saw Carl Goldfischer paying a total of $37,456,813.02 for 5,082,692 shares, this is the most they've acquired in one year. In 2007 Carl Goldfischer cashed out on 4,431,108 shares for a total of $31,478,142.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EnteroMedics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -100.00% | -4.67K |
$4.85 | -$22,639.80 |
0
|
May 25
| |||
Form 4
|
∞
| 4.67K |
$4.85 | $22,639.80 |
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
| +20.67% | 840K |
$1.65 | $1,386,000.00 | 4.9M |
Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +104.70% | 3.33M |
$1.74 | $2,958,000.00 | 6.5M |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +59.31% | 1.65M |
$1.15 | $1,896,907.75 | 4.43M |
Feb 19
| |||
Form 4
| +1.82% | 49.6K |
$1.10 | $54,560.00 | 2.78M |
Oct 24
| |||
Form 4
| +0.92% | 25K |
$4.50 | $112,500.00 | 2.73M |
Apr 29
| |||
Form 4
| +1.88% | 50K |
$4.50 | $225,000.00 | 2.71M |
Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
| +0.80% | 20.99K |
$8.66 | $181,773.40 | 2.66M |
Feb 29
| |||
Form 4
| +602.80% | 2.26M |
—
|
—
| 2.64M |
Nov 20
| |||
Form 4
|
∞
| 375K |
$8.00 | $3,000,000.00 | 375K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MAP Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| -13.09% | -262.79K |
$16.21 | -$4,259,619.76 | 1.74M |
Mar 12 - Mar 16
| |||
Form 4
| -14.48% | -339.91K |
$15.80 | -$5,370,195.70 | 2.01M |
Mar 9 - Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
∞
| 2.35M |
$14.50 | $34,037,310.65 | 2.35M |
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZVUE CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CymaBay Therapeutics, Inc. (CBAY) Snapshot price: $24.155
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$7.21 | -$42,283.35 |
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
$9.11 | -$117,545.00 |
0
|
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
$5.51 | -$113,670.00 |
0
|
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| -95.98% | -46.73K |
$2.74 | -$128,147.17 | 1.96K |
Sep 9 - Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PONIARD PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1,084.46% | 36.15K |
—
|
—
| 39.48K |
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +0.44% | 3.71K |
$5.81 | $21,896.24 | 838.42K |
Aug 30
| |||
Form 4
| +0.09% | 244 |
$5.75 | $1,402.39 | 275.77K |
Aug 29
| |||
Form 4
| +0.05% | 256 |
$5.49 | $1,404.33 | 550.83K |
Aug 14 - Aug 16
| |||
Form 4
| +0.25% | 675 |
$5.50 | $3,712.50 | 275.27K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +25.18% | 55.23K |
$6.33 | $349,586.91 | 274.6K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
∞
| 1.32M |
$0.70 | $921,352.60 | 1.32M |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 20K |
$2.57 | $51,300.00 | 20K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||